ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

SWTX SpringWorks Therapeutics Inc

45.11
1.76 (4.06%)
取引時間後
最終更新日: 05:30:01
15分遅延
名称 銘柄コード 市場 種別
SpringWorks Therapeutics Inc SWTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.76 4.06% 45.11 05:30:01
始値 安値 高値 終値 前日終値
44.09 42.12 45.13 45.11 43.35
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0219:30GLOBESpringWorks Therapeutics Reports First Quarter 2024..
2024/4/2502:31GLOBESpringWorks Therapeutics Announces Abstracts Accepted for..
2024/4/1820:00GLOBESpringWorks Therapeutics to Report First Quarter 2024..
2024/3/0420:30GLOBESpringWorks Therapeutics Initiates Rolling Submission of New..
2024/3/0207:16EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2922:30GLOBESpringWorks Therapeutics Announces European Medicines Agency..
2024/2/2722:28EDGAR2Form 8-K - Current report
2024/2/2722:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2721:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2720:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2720:44EDGAR2Form 8-K - Current report
2024/2/2720:30GLOBESpringWorks Therapeutics Reports Fourth Quarter and Full..
2024/2/2221:00GLOBESpringWorks Therapeutics to Present at Upcoming Investor..
2024/2/2108:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1703:09EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1422:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0611:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0611:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:38EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0306:01EDGAR2Form 8-K - Current report
2024/1/3121:00GLOBESpringWorks Therapeutics to Participate in the Guggenheim..
2024/1/0911:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0911:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0911:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0911:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0911:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0911:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0820:30GLOBESpringWorks Therapeutics Highlights 2023 Accomplishments and..
2023/12/2121:00GLOBESpringWorks Therapeutics to Present at the 42nd Annual J.P...
2023/12/0906:05GLOBESpringWorks Therapeutics Announces Closing of Upsized Public..
2023/12/0706:10EDGAR2Form 8-K - Current report
2023/12/0706:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0514:32GLOBESpringWorks Therapeutics Announces Pricing of Upsized Public..
2023/12/0506:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0506:13GLOBESpringWorks Therapeutics Announces Proposed Public Offering..
2023/11/2921:00GLOBESpringWorks Therapeutics to Participate in the 6th Annual..
2023/11/2823:00EDGAR2Form 8-K - Current report
2023/11/2821:53DJNSpringWorks Shares Rise on FDA Approval for Tumor Treatment
2023/11/2808:46DJNSpringWorks Gets FDA Approval for Desmoid Tumor Treatment
2023/11/2808:04GLOBESpringWorks Therapeutics Announces FDA Approval of OGSIVEO™..
2023/11/1721:00EDGAR2Form 8-K - Current report
2023/11/1620:30GLOBESpringWorks Therapeutics Announces Positive Topline Results..
2023/11/0310:02EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0220:54EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0219:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0219:35EDGAR2Form 8-K - Current report
2023/11/0219:30GLOBESpringWorks Therapeutics Reports Third Quarter 2023..
2023/11/0119:30GLOBESpringWorks Therapeutics Announces Presentation of..
2023/10/0505:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1605:37EDGAR2Form 3 - Initial statement of beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock